HighVista Strategies’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.24M Buy
124,647
+10,598
+9% +$575K 2% 6
2025
Q4
$5.26M Buy
114,049
+27,247
+31% +$1.22M 1.36% 21
2025
Q3
$3.13M Buy
86,802
+53,345
+159% +$1.77M 0.77% 38
2025
Q2
$1.09M Buy
33,457
+355
+1% +$11.6K 0.4% 105
2025
Q1
$1.25M Sell
33,102
-11,559
-26% -$924K 0.48% 96
2024
Q4
$3.66M Hold
44,661
1.36% 11
2024
Q3
$5.1M Buy
44,661
+12,348
+38% +$1.11M 1.76% 3
2024
Q2
$2.44M Buy
32,313
+22,992
+247% +$1.57M 0.89% 33
2024
Q1
$637K Hold
9,321
0.23% 109
2023
Q4
$585K Sell
9,321
-1,927
-17% -$100K 0.21% 113
2023
Q3
$573K Sell
11,248
-3,313
-23% -$163K 0.27% 92
2023
Q2
$727K Sell
14,561
-5,045
-26% -$239K 0.33% 80
2023
Q1
$735K Hold
19,606
0.6% 57
2022
Q4
$940K Sell
19,606
-1,264
-6% -$49.6K 0.56% 48
2022
Q3
$501K Sell
20,870
-7,095
-25% -$180K 0.29% 80
2022
Q2
$609K Buy
+27,965
New +$647K 0.37% 68

Other funds holding PCVX